Open AccessHirsutism following the use of bimatoprost eyedrops for glaucoma
Author(s) -
Subashini Kaliaperumal,
Indu Govindaraj,
Praveen Kumar Kopparapu,
Shashi Ahuja
Publication year - 2014
Publication title -
journal of pharmacology and pharmacotherapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.301
H-Index - 34
eISSN - 0976-5018
pISSN - 0976-500X
DOI - 10.4103/0976-500x.136110
Subject(s) - bimatoprost , medicine , hirsutism , latanoprost , glaucoma , hypertrichosis , chin , ophthalmology , dermatology , prostaglandin analogue , prostaglandin , endocrinology , insulin resistance , polycystic ovary , anatomy , insulin
Prostaglandin F2 alpha (PGF2α) analogues including bimatoprost are often the first line drugs used in the treatment of glaucoma. We present a case of a 62-year-old female patient who was started on bimatoprost in both the eyes for primary open angle glaucoma. The intraocular pressures reached the target level but she developed hair growth over the chin and upper lip after six months of commencing of the treatment. The regional hypertrichosis did not reduce much after stopping the drug. Hirsutism is a potential side effect of prostaglandin analogues which has rarely been reported. Doctors and patients need to be aware of this noticeable and unwanted side effect. The effect seems to occur in patients already having few non-vellus hairs in these areas.